claim
Anti-PD-1/PD-L1 administration ameliorates age-associated functional decline in vivo, including decreased senescence-associated secretory phenotypes (SASPs) and inflammation, while improving alveolar volume, liver fat accumulation, grip strength, and athletic ability.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (2)
- inflammation concept
- senescence-associated secretory phenotype concept